Nephros, Inc. (NEPH)

3.90 +0.14 (+3.72%) USD  |  NASDAQ  |  Feb 13, 14:14
More

Nephros Free Cash Flow : 2.719M for Sept. 30, 2025

Free Cash Flow Chart

View Free Cash Flow for NEPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Apyx Medical Corp. -9.503M
Owlet, Inc. -7.686M
Abbott Laboratories 6.917B
Accuray, Inc. 11.11M
Plus Therapeutics, Inc. -15.78M

Free Cash Flow Related Metrics

Cash from Operations (Quarterly) 0.099M
Cash from Financing (Quarterly) -0.002M
Free Cash Flow Per Share (Quarterly) 0.009
Free Cash Flow to Equity (Quarterly) 0.186M
Free Cash Flow to Firm (Quarterly) 0.099M
Free Cash Flow Yield 6.48%